Life Sciences

Building 3 has been integral to the development of virtually every biotherapeutic produced by Genentech.

Originally constructed in 1981, this vital facility has undergone significant transformation and aging over the years necessitating a comprehensive rehabilitation plan. Eichleay was initially engaged to manage a portfolio of thrity-eight projects with a total installed cost (TIC) of approximately $250 million to extend reliable production of this facility through the year 2020. A Program structure was the best fit for the management of these technically, functionally, and spatially interrelated projects.

$250m

total installed cost (TIC)

The advantage of this approach included:

Single point of responsibility for coordination and oversight of work
Ability to recognize commonalities in scope and execute accordingly

Project needs were addressed globally
The facility knowledge possessed by few was effectively shared with all

High-level program reporting was utilized to assist with decision-making

Services Provided

Architectural
Process
Process Automation
Engineering

Estimating
Scheduling
Project Management
Construction Support

Validation Support
Startup
Commissioning Support

Building 3 Program Management

Previous Project

Next Project

Similar Projects

Eichleay excels at efficiently executing technically complex, fast-track projects that involve many disciplines.

Program Management Consulting Life Sciences

Program Resources for Manufacturing Facility Life Sciences

Seconded Mechanical Engineer Life Sciences

All Projects